Evaluation Of Thyroid Dysfunction In Acute Coronary Syndrome

Evaluation of thyroid dysfunction in acute coronary syndrome

Authors

  • Saurabh Potdar
  • Hetal Patel
  • Nivedita Mehta

Keywords:

SES,sick euthyroid syndrome, STEMI,ST elevation myocardial infaction, UA,unstable angina

Abstract

Background & Objectives: 1} To describe thyroid hormone profile in patients with acute coronary syndromes (ACS) 2} To find, If any, short term prognostic significance of Thyroid diseases. Materials & Methods The study has been carried out at Shree Sayajirao General Hospital and Medical College Baroda during period of March 2011 to May 2012. The study comprised of patients with acute coronary syndrome admitted in ICCU of SSG, Hospital. Inclusion criteria were patients with acute coronary syndrome, irrespective of gender, race, ethnic group, age, and clinical severity, giving consent for being included as a part of the study. Exclusion criteria included patients using corticosteroids, amiodarone, or thyroid disease drugs, who had received any iodinated contrast agent within the previous two weeks, Patients with established diseases, such as neoplasias, chronic renal failure, chronic obstructive pulmonary disease requiring antibiotic therapy, liver cirrhosis, active infection, and decompensated diabetes mellitus, conditions that are known to affect thyroid function tests. Results: Of total 30 pts of STEMI, 30 % had increased level of Free T4 on day 0 and 23.07% had increased values on day 4. Of total 30 pts of NSTEMI/UA, 20 % had increased level of Free T4 on day 0 and 14.28% had increased values on day 4. The levels of TSH, free and Total T3 as well as Total T4 were not significantly different in either STEMI/NSTEMI group either Day 0 or Day 4. 21.67% of pts had evidence of Sick Euthyroid Syndrome on day of admission. Of the total 6 pts expired before day 4, 3 patients had evidence of Sick Euthyroid Syndrome at the time of admission. The association of Sick Euthyroid syndrome was found to be significant for mortality in patients of STEMI with 3 out of 4 expired patients of STEMI having SES at the of admission with significant p value {p <0.05} .There was no significant difference in mortality in patients of NSTEMI/UA having SES. Conclusion: Our results show the importance of recognizing the “Euthyroid Sick Syndrome†in coronary heart disease patients, suggesting an association with poorer prognosis in patients with ST elevated Myocardial Infarction in form of increased mortality and no association was found with mortality in patients having Non ST elevated Myocardial Infarction or Unstable Angina.

References

1. Nagesh S. Anavekar, M.D., John J.V. McMurray, M.D., Eric J. Velazquez, M.D., Scott D. Solomon, M.D., Lars Kober, M.D., D.Sc., Jean-Lucien Rouleau, M.D., Harvey D. White, D.Sc., Rolf Nordlander, M.D., Aldo Maggioni, M.D., Kenneth Dickstein, M.D., Steven Zelenkofske, D.O., Jeffrey D. Leimberger, Ph.D., Robert M. Califf, M.D., and Marc A. Pfeffer, M.D., Ph.D. Cardiovascular Outcomes after Myocardial InfarctionN Engl J Med 2004; 351:1285-1295September 23, 2004DOI: 10.1056/ NEJMoa 041365
2. MENON V, SARNAK MJ: The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: A high risk combination. Am J Kidney Dis 45:223–232, 2005
3. WILSON PW, D’AGOSTINO RB, LEVY D, et al: Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847, 1998
4. SARNAK MJ, LEVEY AS, SCHOOLWERTH AC, et al: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154–2169, 20035. National Kidney Foundation. Kidney Disease Outcome Quality Initiative (K/DOQI) clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39: Suppl 1:S1-S266.
6. Luft FC. Renal disease as a risk factor for cardiovascular disease. Basic Res Cardiol 2000;95:Suppl 1:I72-I76.
7. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am SocNephrol 1998;9: Suppl:S16-S23.
8. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: a new paradigm. Am J Kidney Dis 2000;35:Suppl 1: S117-S131.
9. Chertow GM, Normand SLT, Silva LR, McNeil BJ. Survival after acute myocardial infarction in patients with end-stage renal disease: results from the Cooperative Cardiovascular Project. Am J Kidney Dis 2000; 35:1044-51.
10. Herzog CA, Ma JZ, Collins AJ. Poor longterm survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998;339:799-805.
11. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002;137:563-70.
12. World Health Organization definition of myocardial infarction: 2008–09 revision Shanthi Mendis,1* Kristian Thygesen,2 Kari Kuulasmaa,3 Simona Giampaoli,4 Markku Ma¨ho¨nen,3 Kathleen Ngu Blackett,5 Liu Lisheng6 and Writing group on behalf of the participating experts of the WHO consultation for revision of WHO definition of myocardial infarction International Journal of Epidemiology 2010;1–8 doi:10.1093/ije/dyq165
13. Lakhani S. Early clinical pathologists. Edward Jenner (1749-1823). J ClinPathol 1992;45:756-8

Downloads

Published

2013-10-31

How to Cite

Potdar, S., Patel, H., & Mehta, N. (2013). Evaluation Of Thyroid Dysfunction In Acute Coronary Syndrome: Evaluation of thyroid dysfunction in acute coronary syndrome. National Journal of Integrated Research in Medicine, 4(5), 63–69. Retrieved from http://nicpd.ac.in/ojs-/index.php/njirm/article/view/2232

Issue

Section

Original Articles